蹤獲觴豐

Richard Janeczko has over 30 years of experience in the medical device industry. Richard began their career in 1987 as an Assistant Professor at SUNY. In 1990, they became the CEO of General Synthesis & Diagnostics. In 1997, they took on the role of Executive Vice President and Chief Scientific Officer of TM Bioscience Corp. In 2007, they moved to Luminex Corporation as Executive Vice President of Emerging Markets and Technology. In 2013, they became the CEO of Dx Economix, providing economic impact analyses for medical device companies. Most recently, in 2021, they assumed the role of Chief Technology Officer at Pictor DX.

Richard Janeczko received their PhD in Biochemistry from the University of Alberta in 1980. Richard had previously obtained a Bachelor of Science (BSc) in Biochemistry from the University of Strathclyde in 1973.